Lipidomics collaboration for nutrition research

Nestlé Institute of
Health Sciences (NIHS)

Lipotype GmbH, a Max-Planck spin-off company and the Nestlé Institute of Health Sciences (NIHS) collaborate to employ the innovative Lipotype Shotgun Lipidomics Technology to analyse lipids in blood for nutritional research. Recently, Lipotype and NIHS jointly published results of the robustness of the Lipotype Technology. Lipotype envisions a future use of its technology in clinical diagnostics screens for establishing reliable lipid diagnostic biomarkers.

Click here to read the press release of Nestlé Institute of Health Sciences (NIHS).

Innovative Lipotype Technology for lipid analysis

The purpose of this collaboration is to enable NIHS to use the Lipotype Shotgun Lipidomics Technology for lipid analysis. The mass spectrometry-based Lipotype technology covers a broad spectrum of lipid molecules and delivers quantitative results in high-throughput. The Nestlé Institute of Health Sciences uses this technology platform for nutritional research. NIHS is a specialized biomedical research institute and is part of Nestlé’s global Research & Development network.


Joint research project reveals robustness of Lipotype Technology

During the collaboration, Lipotype and NIHS conducted a joint research project and demonstrated that the Lipotype technology was robust enough to deliver data with high precision and negligible technical variation between different sites.


An Automated Shotgun Lipidomics Platform for High Throughput, Comprehensive, and Quantitative Analysis of Blood Plasma Intact Lipids.

A. Surma, R. Herzog, A. Vasilj, C. Klose, N. Christinat, D. Morin-Rivron, K. Simons, M. Masoodi, and J. L. Sampaio